Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera U.S. Laboratory Partners Revenue Share by Year
U.S. Laboratory Partners Revenue Share (%) (%)
Natera U.S. Laboratory Partners Revenue Share: 3.0% in FY2025, down 1.0 pts from a year earlier. That is the lowest of the 12 years on record here.
Latest, FY2025
3.0%
Period ended Dec 31, 2025
Change on a year earlier
-1.0 pts
4.0% in FY2024
History
12 years
Since FY2014
Sources
7
Documents cited below
Where the FY2025 figure comes from
“The percent of our revenues attributable to U.S. laboratory partners for the years ended December 31, 2025, 2024, and 2023, was 3%, 4% and 6%, respectively.”
Source: Form 10-K (FY2025) ↗
Reported in Form 10-K Business & Form 10-Q Note (2014–2025).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Laboratory Partners Revenue Share (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.0% | -1.0 pts | Form 10-K (FY2025) ↗ |
| FY2024 | Dec 31, 2024 | 4.0% | -2.0 pts | Form 10-K (FY2025) ↗ |
| FY2023 | Dec 31, 2023 | 6.0% | -1.0 pts | Form 10-K (FY2025) ↗ |
| FY2022 | Dec 31, 2022 | 7.0% | +2.0 pts | Form 10-K (FY2024) ↗ |
| FY2021 | Dec 31, 2021 | 5.0% | -2.0 pts | Form 10-K (FY2022) ↗ |
| FY2020 | Dec 31, 2020 | 7.0% | +1.0 pts | Form 10-K (FY2022) ↗ |
| FY2019 | Dec 31, 2019 | 6.0% | +1.0 pts | Form 10-K (FY2021) ↗ |
| FY2018 | Dec 31, 2018 | 5.0% | -1.0 pts | Form 10-K (FY2020) ↗ |
| FY2017 | Dec 31, 2017 | 6.0% | -6.0 pts | Form 10-K (FY2017) ↗ |
| FY2016 | Dec 31, 2016 | 12.0% | +2.0 pts | Form 10-K (FY2017) ↗ |
| FY2015 | Dec 31, 2015 | 10.0% | -16.0 pts | Form 10-K (FY2017) ↗ |
| FY2014 | Dec 31, 2014 | 26.0% | – | Form 10-K (FY2016) ↗ |
Cite this data
StockData. (2026). Natera U.S. Laboratory Partners Revenue Share (%), annual FY2014–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/channel-us-lab-partners-pct
See every metric in the Natera KPI table. Data updated Nov 2, 2026.